By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Endurance RP Limited

Endurance RP Limited (0575.HK)

HKSE Market Data in HKD, Fundamentals in USD
$0.76
-$0.05
-6.17%
Last Update: 12 Sept 2025, 07:20
$221.78M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.32 - $1.24
52 Week Range

0575.HK Stock Price Chart

Explore Endurance RP Limited interactive price chart. Choose custom timeframes to analyze 0575.HK price movements and trends.

0575.HK Company Profile

Discover essential business fundamentals and corporate details for Endurance RP Limited (0575.HK) to support your stock research and investment decisions.

Sector

Financial Services

Industry

Asset Management

IPO Date

19 May 1997

Employees

13.00

CEO

Jamie Alexander Gibson

Description

Endurance RP Limited, an investment holding company, holds investments in the healthcare and life sciences sectors in the People's Republic of China, Europe, Hong Kong, and Taiwan. The company operates in two segments, Biopharma and Corporate Investment. It engages in the research, development, manufacture, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. The company also invests in listed and unlisted corporate entities. In addition, it provides management and corporate finance services. The company was formerly known as Regent Pacific Group Limited and changed its name to Endurance RP Limited in June 2021. Endurance RP Limited was incorporated in 1991 and is headquartered in Central, Hong Kong.

0575.HK Financial Timeline

Browse a chronological timeline of Endurance RP Limited corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 27 Mar 2025

EPS came in at -$0.06 , while revenue for the quarter reached $5.25M .

Earnings released on 29 Aug 2024

EPS came in at -$0.09 , while revenue for the quarter reached $335.83K .

Earnings released on 28 Mar 2024

EPS came in at -$0.44 , while revenue for the quarter reached $1.63M .

Earnings released on 30 Aug 2023

EPS came in at -$0.43 , while revenue for the quarter reached $642.51K .

Stock split effective on 26 Jun 2023

Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.

Stock split effective on 5 Jun 2023

Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 30 Mar 2023

EPS came in at -$1.06 , while revenue for the quarter reached $788.07K .

Earnings released on 30 Aug 2022

EPS came in at -$1.31 , while revenue for the quarter reached $102.00K .

Earnings released on 31 Dec 2021

EPS came in at -$0.99 , while revenue for the quarter reached -$155.95K .

Earnings released on 30 Jun 2021

EPS came in at $0.17 , while revenue for the quarter reached $25.42M .

Earnings released on 31 Dec 2020

EPS came in at $0.23 , while revenue for the quarter reached $12.29M .

0575.HK Stock Performance

Access detailed 0575.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run